Bastide, C <br/><br/>
The role of radical prostatectomy in patients with clinically localized prostate cancer and a prostate-specific antigen level >20 ng/ml.  [electronic resource] 

 -  Prostate cancer and prostatic diseases  2006 
 - 239-44 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article 
<br/><br/><label>ISSN: </label>1365-7852 
<br/><br/><label>Standard No.: </label>10.1038/sj.pcan.4500892  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Carcinoma--drug therapy<br/>Chemotherapy, Adjuvant<br/>Combined Modality Therapy<br/>Disease Progression<br/>Disease-Free Survival<br/>Gonadotropin-Releasing Hormone--agonists<br/>Humans<br/>Male<br/>Neoplasm Staging<br/>Orchiectomy<br/>Prostate-Specific Antigen--blood<br/>Prostatectomy--adverse effects<br/>Prostatic Neoplasms--drug therapy<br/>Retrospective Studies<br/>Survival Analysis<br/>Urinary Incontinence--etiology